TDK U.S.A Corporation
TDK's prototype InCellSenseTM technology platform developed by integrating microfluidics, MEMS and microcontroller digital signal processing capabilities provides a label-free, high-throughput solution to profile cells at the single-cell level using impedance cytometry. This technology platform (not a finished medical device) aims to bring the power of single-cell phenotyping to academic researchers and industrial laboratories. By capturing multiparametric biophysical data and applying integrated AI/ML tools, InCellSenseTM aims to enable accurate single-cell phenotypic classification through its end-to-end capabilities, paired with an intuitive graphical user interface. We are seeking early adopters to collaborate with us to explore and validate new cell biology applications.
Address
San JoseCalifornia
United States
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}